The partnership will provide health plans with an out-of-the-box compliance solution for CMS-9115 and CMS-0057 rules
This partnership aims to accelerate research and development into innovative treatments and, if successful, will generate milestones and royalties
Collaboration with KNAUER to streamline and improve the scale-up of LNP formulations
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Pradaxa Capsules, 110 mg of Boehringer Ingelheim Pharmaceuticals
Lonza Bend (US) upgrades capabilities in early phase clinical manufacturing services with the addition of bottling and labeling equipment
Nelarabine is a nucleoside metabolic inhibitor indicated for the treatment of patients with T-cell acute lymphoblastic leukemia
This product will be manufactured at Lupin’s Nagpur facility in India and will be supplied to low and middle-income countries
Access to breast milk for sick newborns admitted in intensive care units plays a lifesaving role
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
Dabigatran Etexilate Capsules are indicated for reduction of risk of stroke and systemic embolism in non-valvular atrial fibrillation in adult patients
Subscribe To Our Newsletter & Stay Updated
